Futurism collects accounts from people who say peptides bought outside regulated channels have caused unusual health issues.
Recap by typeshit. Full story at Futurism on MSN.
The actor backed Ozempic in an interview while saying exercise has no shortcut. Doctors break down whether his advice holds up.
A BusinessWorld piece on FDA worries about unapproved GLP-1 weight loss drugs, including retatrutide, which is still in trials. Few details were available.
Hecht walks through studies raising concerns that Ozempic and Wegovy may be tied to a rare optic nerve problem that can affect vision.
After his appetite disappeared on tirzepatide, Krasno talks with the Your Best Shot author about food and why scale weight can mask muscle, bone and testosterone loss.
Healio
Edinburgh researchers say known risk factors account for no more than half the drop in heart disease, and Helen Colhoun calls it a cardiovascular drug.
Mean weight loss was 1.5% to 3.2% at day 29. The cash-strapped biotech says the drug is easier on the gut and wants a partner to run phase 2.
Loading…